{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:45:48Z","timestamp":1762004748416},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,10]]},"DOI":"10.18632\/oncotarget.5186","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T21:26:06Z","timestamp":1445203566000},"page":"38336-38347","source":"Crossref","is-referenced-by-count":14,"title":["Better survival of renal cell carcinoma in patients with inflammatory bowel disease"],"prefix":"10.18632","volume":"6","author":[{"given":"Lauranne A.A.P.","family":"Derikx","sequence":"first","affiliation":[{"name":"Inflammatory Bowel Disease Centre, Department of Gastroenterology and Hepatology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Dutch Initiative on Crohn and Colitis (ICC), PALGA group and IBD\/RCC group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loes H.C.","family":"Nissen","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Centre, Department of Gastroenterology and Hepatology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost P.H.","family":"Drenth","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Centre, Department of Gastroenterology and Hepatology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla M.","family":"van Herpen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wietske","family":"Kievit","sequence":"additional","affiliation":[{"name":"Radboud Institute for Health Sciences, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob H.A.","family":"Verhoeven","sequence":"additional","affiliation":[{"name":"Netherlands comprehensive cancer organization \/ Netherlands Cancer Registry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter F.A.","family":"Mulders","sequence":"additional","affiliation":[{"name":"Department of Urology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina A.","family":"Hulsbergen-van de Kaa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marye J.","family":"Boers-Sonderen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim R.A.","family":"van den Heuvel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke","family":"Pierik","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris D.","family":"Nagtegaal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Hoentjen","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Centre, Department of Gastroenterology and Hepatology, Radboud university medical centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,5]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Mayberry","year":"2001","journal-title":"Gut"},{"key":"2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies","volume":"105","author":"Jess","year":"2010","journal-title":"The American journal of gastroenterology"},{"key":"3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/gutjnl-2011-301133","article-title":"Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?","volume":"61","author":"Beaugerie","year":"2012","journal-title":"Gut"},{"key":"4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/gutjnl-2013-305300","article-title":"The management of immunosuppression in patients with inflammatory bowel disease and cancer","volume":"62","author":"Itzkowitz","year":"2013","journal-title":"Gut"},{"key":"5","article-title":"Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer","author":"Peyrin-Biroulet","year":"2013","journal-title":"Gut"},{"key":"6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/MIB.0000000000000243","article-title":"Cancer and immunomodulators in inflammatory bowel diseases","volume":"21","author":"Pallone","year":"2015","journal-title":"Inflammatory bowel diseases"},{"key":"7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000353382","article-title":"Use of immunosuppressants and biologicals in patients with previous cancer","volume":"31","author":"Beaugerie","year":"2013","journal-title":"Digestive diseases"},{"key":"8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Group","year":"2009","journal-title":"Lancet"},{"key":"9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease","volume":"141","author":"Beaugerie","year":"2011","journal-title":"Gastroenterology"},{"key":"10","article-title":"Risk of Cancer in Patients with Inflammatory Bowel Diseases: a Nationwide Population-Based Cohort Study with 30 Years of Follow Up","author":"Baron","year":"2013","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"key":"11","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jacobsen","year":"2013","journal-title":"The American journal of gastroenterology"},{"key":"12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3109\/00365521.2013.846402","article-title":"Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland","volume":"48","author":"Farkkila","year":"2013","journal-title":"Scandinavian journal of gastroenterology"},{"key":"13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review","volume":"67","author":"Campistol","year":"2007","journal-title":"Drugs"},{"key":"14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MEG.0b013e328365ac54","article-title":"Severe exacerbation of Crohn's disease during sunitinib treatment","volume":"26","author":"van Herpen","year":"2014","journal-title":"European journal of gastroenterology & hepatology"},{"key":"15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00467-008-0773-6","article-title":"Renal cell carcinoma in a patient with cystinosis and inflammatory bowel disease: a case report","volume":"23","author":"Kelly","year":"2008","journal-title":"Pediatric nephrology"},{"key":"16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gut.38.1.148","article-title":"Ulcerative colitis complicated by renal cell carcinoma: a series of three patients","volume":"38","author":"Jewell","year":"1996","journal-title":"Gut"},{"key":"17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/gut.38.6.936-b","article-title":"Ulcerative colitis and renal cell carcinoma","volume":"38","author":"Plaisier","year":"1996","journal-title":"Gut"},{"key":"18","first-page":"251","article-title":"[The possible pathogenesis of AA type amyloidosis in a patient with ulcerative colitis and renal cell carcinoma]","volume":"60","author":"Polenakovic","year":"2006","journal-title":"Acta medica Croatica: casopis Hravatske akademije medicinskih znanosti"},{"key":"19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1023\/A:1022805329847","article-title":"Linear IgA bullous dermatosis: an association with ulcerative colitis versus renal cell carcinoma","volume":"48","author":"Davis","year":"2003","journal-title":"Digestive diseases and sciences"},{"unstructured":"http.\/\/www.zorgatlas.nl\/zorg\/ziekenhuiszorg\/algemene-en-academische-ziekenhuizen\/aanbod\/locaties-algemene-en-academische-ziekenhuizen.","key":"20"},{"key":"21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/003655902762467558","article-title":"Renal cell carcinoma: gender difference in incidental detection and cancer-specific survival","volume":"36","author":"Beisland","year":"2002","journal-title":"Scandinavian journal of urology and nephrology"},{"key":"22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.juro.2011.09.025","article-title":"Incidental detection of renal cell carcinoma is an independent prognostic marker: results of a long-term, whole population study","volume":"187","author":"Gudbjartsson","year":"2012","journal-title":"The Journal of urology"},{"key":"23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0302-2838(03)00142-8","article-title":"Incidental detection beyond pathological factors as prognostic predictor of renal cell carcinoma","volume":"43","author":"Pagano","year":"2003","journal-title":"European urology"},{"key":"24","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.urology.2005.07.009","article-title":"Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients","volume":"66","author":"Einarsson","year":"2005","journal-title":"Urology"},{"key":"25","first-page":"S395","article-title":"P628. Anti-TNF treatment and renal cell carcinoma in patients with inflammatory bowel disease, rheumatoid arthritis and spondyloarthropathy: trigger or cure?","volume":"1","author":"Ferrante","year":"2015","journal-title":"Journal of Crohn's & colitis"},{"key":"26","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s00535-012-0603-2","article-title":"Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey","volume":"47","author":"van der Woude","year":"2012","journal-title":"Journal of gastroenterology"},{"key":"27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ibd.20542","article-title":"Two distinct groups of colorectal cancer in inflammatory bowel disease","volume":"15","author":"Vatn","year":"2009","journal-title":"Inflammatory bowel diseases"},{"key":"28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/MIB.0b013e318280ebbd","article-title":"Risk of extraintestinal solid cancer with anti-TNF therapy in adults with inflammatory bowel disease: review of the literature","volume":"19","author":"Sands","year":"2013","journal-title":"Inflammatory bowel diseases"},{"key":"29","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Emery","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"key":"30","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00007890-199304000-00011","article-title":"The effect of immunosuppression on pre-existing cancers","volume":"55","author":"Penn","year":"1993","journal-title":"Transplantation"},{"key":"31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.bjc.6605889","article-title":"A phase I\/II trial of sorafenib and infliximab in advanced renal cell carcinoma","volume":"103","author":"Gore","year":"2010","journal-title":"British journal of cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1200\/JCO.2007.11.2136","article-title":"Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose","volume":"25","author":"DeWitte","year":"2007","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"33","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.ejca.2008.04.014","article-title":"No improvement in renal cell carcinoma survival: a population-based study in the Netherlands","volume":"44","author":"van Spronsen","year":"2008","journal-title":"European journal of cancer"},{"key":"34","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Meijer","year":"2007","journal-title":"Cellular oncology: the official journal of the International Society for Cellular Oncology"},{"key":"35","article-title":"Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL)","author":"Pierik","year":"2015","journal-title":"International journal of epidemiology"},{"key":"36","article-title":"Cancer incidence, care and survival in the South of the Netherlands 1955-1999, a report from the Eindhoven Cancer Registry with cross-border implications","author":"Voogd","year":"2001","journal-title":"Comprehensive Cancer Centre South (ECR), Eindhoven"},{"key":"37","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/oxfordjournals.aje.a009735","article-title":"Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study","volume":"149","author":"Wajda","year":"1999","journal-title":"American journal of epidemiology"},{"key":"38","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/ibd.21285","article-title":"Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort","volume":"16","author":"Stockbrugger","year":"2010","journal-title":"Inflammatory bowel diseases"},{"key":"39","article-title":"Why match? Investigating matched case-control study designs with causal effect estimation","volume":"5","author":"Laan","year":"2009","journal-title":"The international journal of biostatistics"},{"unstructured":"http.\/\/www.eindhovencancerregistry.nl.","key":"40"},{"key":"41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ije\/22.3.369","article-title":"Completeness of cancer registration in Limburg, The Netherlands","volume":"22","author":"Jager","year":"1993","journal-title":"International journal of epidemiology"},{"key":"42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Limas","year":"1982","journal-title":"The American journal of surgical pathology"},{"volume-title":"Epidemiology: an introduction","year":"2012","author":"Rothman","key":"43"},{"key":"44","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511610806","volume-title":"Applied Multilevel Analysis: A Practical Guide","author":"Twisk","year":"2006"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T11:39:17Z","timestamp":1594813157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,5]]},"references-count":44,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2015,11,10]]}},"alternative-id":["5186","26447542"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5186","relation":{},"ISSN":["1949-2553"],"issn-type":[{"type":"electronic","value":"1949-2553"}],"subject":[],"published":{"date-parts":[[2015,10,5]]}}}